Thermo Fisher Scientific Inc (TMO): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Thermo Fisher Scientific ( TMO) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.6%. By the end of trading, Thermo Fisher Scientific rose $1.23 (1.1%) to $114.43 on average volume. Throughout the day, 2,389,830 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1,885,500 shares. The stock ranged in a price between $113.27-$114.78 after having opened the day at $113.57 as compared to the previous trading day's close of $113.20. Other companies within the Health Services industry that increased today were: Misonix ( MSON), up 16.7%, Biolase ( BIOL), up 13.9%, OraSure Technologies ( OSUR), up 10.3% and EnteroMedics ( ETRM), up 9.7%.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $40.8 billion and is part of the health care sector. Shares are up 1.7% year to date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front, Alere ( ALR), down 8.0%, Medical Action Industries ( MDCI), down 8.0%, SunLink Health Systems ( SSY), down 7.2% and Akers Biosciences ( AKER), down 5.6% , were all laggards within the health services industry with Covance ( CVD) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Jim Cramer: Agilent Technology Has Been One of My Favorites

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Cramer: Secondary Offerings Get Primary Attention

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria